GE Appoints Three New Company Officers
June 28, 2011
FAIRFIELD, Conn.--28 June 2011-- GE today announces the appointment of three new company officers. GE currently has 194 GE officers globally who lead large revenue generating businesses or are in critical functional roles, helping to drive growth. Below are the details of GE’s new company officers: Gary D. Mercer, 52, has been named Vice President [...]
June 28, 2011
454 Life Sciences, a Roche Company (SIX: RO, ROG; OTCQX: RHHBY), announced today the launch and immediate availability of the new GS FLX+ System, an instrument capable of generating extra-long sequencing reads up to 1,000 by in length. This new level of performance presents a major milestone in the life science’s industry, making it the [...]
Genetic Technologies Executes Settlement and License Agreement with Navigenics Inc
June 28, 2011
In compliance with ASX Continuing Disclosure Rules, Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to report that it has now executed a Settlement and License Agreement with Navigenics Inc. (“Navigenics”) of Foster City, California. Navigenics was a counterparty to the Company’s recently announced patent infringement suit filed in the District Court of Colorado [...]
Coriell Institute and NIH Provide Scientists With Powerful New Stem Cells
June 27, 2011
CAMDEN, N.J. – Coriell Institute for Medical Research announced today the availability of powerful new stem cells to the scientific research community. These cells – called induced pluripotent stem cells – possess many of the important properties of embryonic stem cells. However, they bypass controversy as they can be made from skin cells or blood [...]
June 27, 2011
HOPKINTON, Mass. and GAITHERSBURG, Md. - Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a collaboration with Edge BioSystems, Inc., an innovative sequencing service provider based in Gaithersburg, Md. EdgeBio and Caliper will co-develop automated protocols for the 5500xl, SOLiD 4, and Ion Torrent Personal Genome Machine (PGM) systems on Caliper’s Sciclone® NGS Workstation, and [...]
Oxford Nanopore appoints Peter Allen to Board
June 27, 2011
OXFORD, UNITED KINGDOM - Oxford Nanopore Technologies Ltd is pleased to announce the appointment of Peter Allen ACA to its board. Peter Allen joins the board of Oxford Nanopore as non executive Director with broad, senior experience in the life sciences industries. He currently serves as Non-Executive Chairman on the Boards of ProStrakan Group plc, [...]
Thermo Fisher Scientific Announces Breakthrough Workflow for Metabolomics Research
June 27, 2011
CAIRNS, Australia - Thermo Fisher Scientific Inc., the world leader in serving science, today announced a breakthrough workflow to overcome key analytical and informatics challenges in metabolomics. The workflow integrates new application software -- Thermo Scientific SIEVE 2.0 differential expression analysis and Mass Frontier 7.0 structural elucidation software -- with powerful new Thermo Scientific high [...]
Food Safety Testing Simplified and Accelerated with Pall GeneDisc® Cycler
June 27, 2011
PORT WASHINGTON, N.Y. - Pall Corporation (NYSE:PLL), today introduced its new GeneDisc® Cycler to test food for pathogens and spoilage organisms. This pathogen detection system enables testing of up to 96 samples in as little as one hour, compared with several days using traditional methods. Operating on a robust Real Time Polymerase Chain Reaction (RT [...]
Gene Codes’ Sequencher 5.0 Delivers Next-generation DNA Sequence Analysis
June 27, 2011
Gene Codes Corporation announces the release of Sequencher 5.0. It incorporates new DNA sequence data alignment algorithms with SNP and methylation analysis for next-generation DNA sequence data. Performance for assembly and alignment of sequences and contigs is hundreds of times faster. New alignment functions and database searching features make getting reliable results from both capillary [...]
AltheaDx Incorporates Next-Generation Sequencing Into Its Clinical Testing Pipeline.
June 27, 2011
SAN DIEGO - AltheaDx, Inc. today announced the launch of next-generation sequencing “NGS” services into its clinical molecular pathology lab for application in biomarker discovery and clinical trial testing. AltheaDx intends to utilize NGS for both monitoring known and discovering new complex genetic changes that underlie different cancer types. “The addition of NGS greatly expands [...]
